NCT01479972: Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa |
|
|
| Completed | 2 | 48 | RoW | VPM1002, BCG | Vakzine Projekt Management GmbH, Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa, Triclinium Johannesburg, South Africa, University of Stellenbosch, HJ-CTC George, South Africa | Tuberculosis | 11/12 | 11/12 | | |
NCT02391415: Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa |
|
|
| Completed | 2 | 416 | RoW | VPM1002, recombinant BCG for TB, BCG, VPM1002(Hyg+) | Serum Institute of India Pvt. Ltd., Vakzine Projekt Management GmbH, Triclinium Clinical Trial Project Management, Children's Infectious Diseases Clinical Research Unit (KID-CRU), Desmond Tutu TB Centre, The Respiratory and Meningeal Pathogens Research Unit (RMPRU), South African Tuberculosis Vaccine Initiative, University of Stellenbosch | Tuberculosis | 11/17 | 11/17 | | |
